Peachtree City company warned about promoting unapproved drugs

Peachtree City company warned about promoting unapproved drugs

A Peachtree City company is the latest Georgia dietary supplement maker facing federal sanctions for unsubstantiated claims that their products can cure, treat, or prevent diseases. It is also the latest dietary supplement company targeted by federal authorities for promoting the use of products with microscopic amounts of silver, called colloidal silver, to ward off […]

CFDRC Acquires Drug-Discovery Division of iXpressGenes

CFDRC Acquires Drug-Discovery Division of iXpressGenes

NEW YORK (GenomeWeb) – CFD Research Corporation (CFDRC) has acquired the microbiome-based drug discovery division of iXpressGenes (iXG) for an undisclosed amount. CFDRC and iXpressGenes are both associate companies of the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. As part of the acquisition, CFDRC obtained iXG’s high-throughput antimicrobial discovery platform, EMAD (extremophilic microbiome antimicrobial discovery), […]

Members Move Medicine: Helping patients wherever they are

Members Move Medicine: Helping patients wherever they are

The AMA Wire® “Members Move Medicine” series profiles a wide variety of doctors, offering a glimpse into the passions of women and men navigating new courses in American medicine. On the move with: Moudi Hubeishy, a medical student at State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences. He leads […]

Teva's Migraine Drug Fails in Phase 3 for Chronic Cluster Headaches

Teva's Migraine Drug Fails in Phase 3 for Chronic Cluster Headaches

Xconomy National —  Teva Pharmaceutical’s bid to add a new therapeutic application for its experimental migraine-prevention drug has faltered in a late-stage study. Israel-based Teva (NYSE: TEVA) said Friday that it is stopping a Phase 3 clinical trial testing its drug, fremanezumab, for prevention of chronic cluster headaches. According to the company, an analysis found […]

RSV Vaccine Clinical Trial Launched by Cincinnati Children's Hospital

RSV Vaccine Clinical Trial Launched by Cincinnati Children's Hospital

An investigational vaccine designed to protect people against respiratory syncytial virus (RSV) has launched a small clinical trial. This study, being conducted at the Cincinnati Children’s Hospital, is important since there is not a specific treatment or vaccine available for RSV. Anthony S. Fauci, M.D., said in a press release, “A vaccine to prevent the […]

Bristol-Myers' Opdivo ushers in a new era as the first IO therapy approved in China

Bristol-Myers' Opdivo ushers in a new era as the first IO therapy approved in China

In a historic moment for China’s medical world, China’s Drug Administration on Friday approved Opdivo, the country’s first immuno-oncology—and the first PD-1—therapy. For developer Bristol-Myers Squibb, though, the time for celebration won’t last long, as there’re many more to come, including its archnemesis Keytruda. Different from its world-first and U.S.-first indication of melanoma, Opdivo goes […]

New £56m investment in Scotland to strengthen the UK's place in the global pharma industry

New £56m investment in Scotland to strengthen the UK's place in the global pharma industry

A new £56 million UK innovation centre, which will revolutionise how medicines are manufactured, is to be located in Renfrewshire. Protecting future generations by bringing new medicines to market safely and quickly is one of the biggest health challenges facing the world today. A world-first, the new industry-led Medicines Manufacturing Innovation Centre (MMIC) will offer […]

Can Sprout Pharma's Latest Revival Really Boost VRX Stock?

Can Sprout Pharma's Latest Revival Really Boost VRX Stock?

At the height of its success, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) thought it could buy drug companies in the billion-dollar range, raise prices and profit. That includes the time the company bought Sprout back in 2015. That gave it access to Addyi, a female libido drug. We all know how that story unfolded. Now, Sprout Pharmaceuticals […]

New compound as effective as FDA-approved drugs against life-threatening infections

New compound as effective as FDA-approved drugs against life-threatening infections

IMAGE: This group of researchers worked with Purdue chemistry professor Herman Sintim to identify a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved… view more  Credit: (Image provided) WEST LAFAYETTE, Ind. – Purdue University researchers have identified a new compound that in preliminary testing has shown itself to […]